TILIA FIDUCIARY PARTNERS, INC. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
TILIA FIDUCIARY PARTNERS, INC. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$15,186
-21.4%
6000.0%0.01%
-22.2%
Q1 2023$19,326
+74.5%
6000.0%0.02%
+63.6%
Q4 2022$11,076
-34.8%
6000.0%0.01%
-35.3%
Q3 2022$17,000
+88.9%
6000.0%0.02%
+88.9%
Q2 2022$9,000
-25.0%
6000.0%0.01%
-10.0%
Q1 2022$12,000
+20.0%
6000.0%0.01%
+25.0%
Q4 2021$10,0006000.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 4,592,047$156,130,00032.47%
Camber Capital Management LP 630,000$21,420,0001.40%
Granite Point Capital Management, L.P. 50,000$1,700,0001.17%
Rhenman & Partners Asset Management AB 82,000$2,788,0000.83%
Geduld E E 25,001$850,0000.53%
Pier Capital, LLC 106,985$3,637,0000.52%
Ghost Tree Capital, LLC 20,000$680,0000.48%
ArrowMark Colorado Holdings LLC 433,457$14,738,0000.42%
Polar Capital LLP 577,042$19,618,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 256,500$8,721,0000.35%
View complete list of REVANCE THERAPEUTICS INC shareholders